Vazquez-Jimenez et al. suggest that RGS2 overexpression precedes insulin resistance, and that elevated RGS2 protein levels are sufficient to inhibit insulin signaling in human endothelial cells (or sufficient to trigger insulin resistance in human endothelial cells) [102]. The gene discussed is RGS2; the disease is Insulin resistance.